发文地区与机构
近年国家 / 地区发文量统计
| 国家 / 地区 | 发文量 |
|---|---|
| USA | 155 |
| CHINA MAINLAND | 137 |
| England | 99 |
| Japan | 94 |
| India | 49 |
| GERMANY (FED REP GER) | 43 |
| Denmark | 41 |
| Italy | 41 |
| Wales | 29 |
| Sweden | 28 |
近年机构发文量统计
| 机构 | 发文量 |
|---|---|
| NOVO NORDISK | 50 |
| ELI LILLY | 43 |
| SANOFI-AVENTIS | 32 |
| BHARTI HOSP | 21 |
| UNIV HOSP LLANDOUGH | 21 |
| UNIVERSITY OF LONDON | 21 |
| MERCK & COMPANY | 17 |
| BOEHRINGER INGELHEIM | 15 |
| UNIVERSITY OF LIVERPOOL | 15 |
| CHINESE ACADEMY OF MEDICAL SCIENCES - P... | 14 |
文章引用情况
1
A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus2
Combination Treatment of SGLT2 Inhibitors and GLP-1 Receptor Agonists: Symbiotic Effects on Metabolism and Cardiorenal Risk3
Serum Antioxidant Parameters are Significantly Increased in Patients with Type 2 Diabetes Mellitus after Consumption of Chinese Propolis: A Randomized Controlled Trial Based on Fasting Serum Glucose Level4
Meta-Analysis of Sulfonylurea Therapy on Long-Term Risk of Mortality and Cardiovascular Events Compared to Other Oral Glucose-Lowering Treatments5
Prevalence of Established Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in the UK6
EADSG Guidelines: Insulin Storage and Optimisation of Injection Technique in Diabetes Management7
Efficacy of Dulaglutide as a First Injectable Option for Patients with Type 2 Diabetes: A Post-Hoc Pooled Analysis8
Pharmacovigilance Evaluation of the Association Between DPP-4 Inhibitors and Heart Failure: Stimulated Reporting and Moderation by Drug Interactions9
Evidence-Based Consensus on Positioning of SGLT2i in Type 2 Diabetes Mellitus in Indians10
Efficacy and Safety of Alirocumab in Individuals with Diabetes Mellitus: Pooled Analyses from Five Placebo-Controlled Phase 3 Studies